Medical Use
Jaypirca is a kinase inhibitor used to treat adult patients with relapsed or refractory mantle cell lymphoma (MCL) who have undergone at least two lines of systemic therapy, including a BTK inhibitor. This indication has received accelerated approval based on response rates, with continued approval dependent on confirmatory trials verifying clinical benefits.
Dosage
Recommended Dosage: Take 200 mg orally once daily. Swallow the tablet whole with water, with or without food. Do not cut, crush, or chew the tablets.
Managing Toxicity: Toxicity can be managed by interrupting treatment, reducing the dosage, or discontinuing use as necessary.
Patients with Severe Renal Impairment: Reduce the dosage for patients with severe renal impairment.
Contraindications: None.
Warning & Precautions
Infections: Keep an eye out for signs and symptoms of infection, evaluate promptly, and treat as needed.
Hemorrhage: Monitor for any bleeding and manage it appropriately.
Cytopenias: Regularly check complete blood counts during treatment.
Atrial Fibrillation and Atrial Flutter: Be alert for symptoms of arrhythmias and manage them as necessary.
Second Primary Malignancies: Other cancers, including skin cancers and other carcinomas, have been reported. Monitor patients and advise them to use sun protection.
Embryo-Fetal Toxicity: Jaypirca can harm a fetus. Women of reproductive potential should be informed about the potential risks to a fetus and advised to use effective contraception.
Documentation Availability
Documents required to import Jaypirca to India?
Jaypirca (pirtobrutinib) Tablets can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:
- (i)2 ID proofs along with PAN card details along with attested scanned copies
- (ii)Valid doctor prescription scanned copy
- (iii)Doctor’s MCI number
- (iv)Doctor’s mobile number
- (v)Patients diagnostic reports
How is the order confirmed?
The order will be confirmed only after the receipt of:
- (i)The above-mentioned documents and drug availability.
- (ii)Import permit if applicable.
Sourcing & Delivery
The Rx4U team has extensive experience in sourcing Jaypirca (pirtobrutinib) (Cancer Treatment Medicines) from around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.
FAQ
What is Jaypirca?
Jaypirca is a medication used to treat mantle cell lymphoma (MCL) in adults who have relapsed or refractory MCL after at least two lines of systemic therapy, including a BTK inhibitor.
How do I take Jaypirca?
Jaypirca is taken orally once daily with water. Swallow the tablet whole, and it can be taken with or without food. Do not cut, crush, or chew the tablets.
Is a prescription required for Jaypirca?
Yes, you need a prescription from a healthcare provider to obtain Jaypirca. Your healthcare provider will determine your eligibility and prescribe the appropriate dosage.
What are the common side effects of Jaypirca?
Common side effects of Jaypirca include fatigue, musculoskeletal pain, diarrhea, edema, shortness of breath, pneumonia, and bruising. Discuss any side effects with your healthcare provider.
Is Jaypirca FDA approved?
Yes, Jaypirca was approved by the FDA in 2023.
Is it safe to buy Jaypirca online in India?
Yes, you can safely purchase Jaypirca online in India through https://rx4u.in/.
*Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide Information.
